Xcout Intel
ADIPO THERAPEUTICS, LLC
Adipo Therapeutics is a biotechnology company developing treatments for obesity and metabolic-related diseases. The company utilizes Notch-inhibiting nanoparticles to convert energy-storing white fat into energy-burning brown fat to increase energy expenditure and resting metabolic rate.
Subscribe to see ADIPO THERAPEUTICS, LLC’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
ADIPO THERAPEUTICS, LLC at a glance
ADIPO THERAPEUTICS, LLC is a biotechnology company headquartered in United States. Its most recent funding round, Seed, raised $1M in May 2025. Xcout tracks 12 named people at ADIPO THERAPEUTICS, LLC, including Karen Wurster (CEO).
ADIPO THERAPEUTICS, LLC leadership
- Karen WursterCEO
- Keith JohnsChief Operating Officer
- Tom GabbertFractional CFO
- HARDY THOMASChief Medical Officer
- Meng DengFounder and Chief Scientist
- Sumitra GhateSenior Vice President of Product Development and Global Regulatory Affairs
6 more named people on record for ADIPO THERAPEUTICS, LLC, with roles, board committees and tenure — see the full roster →
ADIPO THERAPEUTICS, LLC funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $1M | 4 named | |
| SEC Form D filing | $4.7M | — | |
| Seed | $2.8M | 5 named | |
| SEC Form D filing | $1.3M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
ADIPO THERAPEUTICS, LLC competitors
A few of ADIPO THERAPEUTICS, LLC's closest competitors — see the full list of competitors and alternatives →
AdipoPharma is a French biotech company dedicated to understanding the role of adipocyte cells in diabetes, focusing on lipid biosynthesis and whole-body metabolic health.
Carmot Therapeutics, Inc. is a biopharmaceutical company headquartered in Berkeley, California, focused on discovering and developing innovative treatments for metabolic diseases and obesity.
Adocia is a clinical-stage biotechnology company that develops innovative formulations of proteins, peptides, and metabolic hormones. The company specializes in creating treatments for diabetes and obesity, as well as immunoprotective scaffolds for cell therapies.
Parabolica Therapeutics develops proprietary peptide conjugation technologies focused on obesity and other metabolic conditions. The company researches and advances therapeutic programs through its scientific approach.
Atrogi is a clinical-stage biotechnology company headquartered in Stockholm, Sweden, pioneering the development of novel treatments for metabolic disorders.
Inversago Pharma is a Canadian biotechnology company developing peripherally restricted CB1 receptor antagonists/inverse agonists for metabolic, fibrotic, and related diseases. Its drug-development programs are intended to serve patients with conditions such as obesity, metabolic syndrome, and diabetic kidney disease.
Get ADIPO THERAPEUTICS, LLC's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on ADIPO THERAPEUTICS, LLC in Xcout Intel
- 12 named people with titles, LinkedIn and board committees
- 4 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access